Equity derivatives house of the year: UBS

julien-bahurel
Julien Bahurel

Innovative products pulling in more than $950 million in Taiwan and $1.4 billion in Japan illustrate UBS's commitment to strengthening its foothold across Asia.

Despite difficult market conditions and a marked slowdown in activity in parts of the region, the bank has been expanding its presence in countries such as China, South Korea and Taiwan, as well as in Hong Kong's wealth management segment, aiming for a balance between retail, private banking and institutional coverage.

"UBS is very good

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Environmental products house of the year: ENGIE

ENGIE is driving change in energy transition, with a strong focus on renewable energy and the liberalisation of power markets in Apac, which presents significant long-term growth opportunities. In recognition of its efforts, ENGIE GEMS has been named…

Newcomer of the year: Topaz Technology

Jon Fox and former colleagues formed Topaz Technology in 2015. Having seen many different systems and, in some cases, written and built a few themselves, there was always something missing, leading them to build a system that unifies risk reporting and…

Technology vendor of the year: Murex

As a technology vendor, Murex places adaptability front and centre of everything it does, constantly enriching its MX.3 platform to ensure institutions can respond to new market opportunities as soon as they spot them

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here